
OCULAR THERAPEUTIX, INC — Investor Relations & Filings
Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of therapies for diseases and conditions of the eye. The company's primary focus is on transforming the treatment of retinal diseases, such as wet age-related macular degeneration (wet AMD), a leading cause of blindness. Ocular Therapeutix utilizes its proprietary hydrogel-based drug delivery platform, ELUTYX™, to develop sustained-release therapies. This technology is designed to reduce the therapeutic burden on patients by decreasing the frequency of required treatments. The company's lead product candidate, AXPAXLI™ (axitinib intravitreal implant), is in late-stage clinical development for major retinal diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - OCULAR THERAPEUTIX, INC (0001393434) (Filer) | 2026-05-05 | English | |
| 8-K - OCULAR THERAPEUTIX, INC (0001393434) (Filer) | 2026-05-05 | English | |
| 8-K - OCULAR THERAPEUTIX, INC (0001393434) (Filer) | 2026-02-27 | English | |
| 4 - OCULAR THERAPEUTIX, INC (0001393434) (Filer) | 2026-02-26 | English | |
| 4 - OCULAR THERAPEUTIX, INC (0001393434) (Filer) | 2026-02-26 | English | |
| 4 - OCULAR THERAPEUTIX, INC (0001393434) (Filer) | 2026-02-26 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
OCULAR THERAPEUTIX, INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31615/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31615 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31615 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31615 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31615}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OCULAR THERAPEUTIX, INC (id: 31615)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.